InfuSystem Holdings Inc

Research InfuSystem Holdings Inc (INFU) on Bullrun: valuation model: 10.2% undervalued, market cap USD 199.40M, P/E 26.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINFU
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal10.2% undervalued
• Market capUSD 199.40M
• P/E26.2
• Financial periodFY2025
• RevenueUSD 143.44M
• Revenue growth6.4%
• Net incomeUSD 6.63M
• Free cash flowUSD 23.85M
• Gross margin56.0%

Valuation Snapshot

Bullrun's latest valuation model marks InfuSystem Holdings Inc as 10.2% undervalued; latest market cap is USD 199.40M; P/E is 26.2.

About InfuSystem Holdings Inc

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Frequently asked questions

Is InfuSystem Holdings Inc overvalued or undervalued?

Bullrun's valuation model currently marks InfuSystem Holdings Inc as 10.2% undervalued.

What is InfuSystem Holdings Inc's market cap?

InfuSystem Holdings Inc's market capitalization is USD 199.40M.

What is InfuSystem Holdings Inc's P/E ratio?

InfuSystem Holdings Inc's price-to-earnings (P/E) ratio is 26.2.

What does InfuSystem Holdings Inc do?

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.